Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03492918 |
|---|---|
| Brief Title: | Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16) |
| First Submitted : | April 1, 2018 |
| First Submitted that Met QC Criteria : | April 8, 2018 |
| First Posted : | April 10, 2018 |
| Last Update Submitted that Met QC Criteria : | March 14, 2022 |
| Last Update Posted : | March 15, 2022 |